Pharmaceutical companies and even some high-tech companies such as General Electric are pushing back – countering that some of the changes their opponents want could reduce protections for patent-holders by limiting the damages innovators could seek from copycats.
The Wisconsin Alumni Research Foundation, which patents the discoveries of University of Wisconsin-Madison researchers, has some of those same concerns.